GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast AS (OTCPK:CLPBF) » Definitions » Ending Cash Position

CLPBF (Coloplast AS) Ending Cash Position : $106 Mil (As of Mar. 2025)


View and export this data going back to 2013. Start your Free Trial

What is Coloplast AS Ending Cash Position?

Coloplast AS's Ending Cash Position for the quarter that ended in Mar. 2025 was $106 Mil.

Coloplast AS's quarterly Ending Cash Position increased from Sep. 2024 ($117 Mil) to Dec. 2024 ($127 Mil) but then declined from Dec. 2024 ($127 Mil) to Mar. 2025 ($106 Mil).

Coloplast AS's annual Ending Cash Position increased from Sep. 2022 ($55 Mil) to Sep. 2023 ($130 Mil) but then declined from Sep. 2023 ($130 Mil) to Sep. 2024 ($117 Mil).


Coloplast AS Ending Cash Position Historical Data

The historical data trend for Coloplast AS's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast AS Ending Cash Position Chart

Coloplast AS Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 51.15 70.88 55.08 130.37 117.30

Coloplast AS Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 129.60 127.93 117.30 127.21 105.66

Coloplast AS Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Coloplast AS's Ending Cash Position for the fiscal year that ended in Sep. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=130.396+-13.099
=117

Coloplast AS's Ending Cash Position for the quarter that ended in Mar. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=131.317+-25.654
=106


Coloplast AS Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Coloplast AS's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Coloplast AS Business Description

Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast AS Headlines

From GuruFocus

Coloplast A/S's Dividend Analysis

By GuruFocus Research 05-17-2024

Q2 2021 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q1 2025 Coloplast A/S Earnings Call Transcript

By GuruFocus News 02-05-2025

Coloplast A/S Annual Shareholders Meeting Transcript

By GuruFocus Research 02-13-2024

Q4 2023 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q4 2022 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Coloplast A/S Virtual ESG Event Call Transcript

By GuruFocus Research 02-13-2024